ABT
Price
$109.35Alerts
Change
-$1.11 (-1.00%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
190.22B
76 days until earnings call
Intraday BUY SELL Signals
ZBH
Price
$107.47Alerts
Change
+$0.15 (+0.14%)
Updated
Nov 11 closing price
Capitalization
20.14B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABT vs ZBH

ABT vs ZBH Comparison Chart in %
View a ticker or compare two or three
VS
ABT vs. ZBH commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and ZBH is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ABT with price predictions
Nov 11, 2026

ABT in upward trend: 10-day moving average broke above 50-day moving average on November 02, 2026

The 10-day moving average for ABT crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on ABT as a result. In 42 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.

The Moving Average Convergence Divergence (MACD) for ABT just turned positive on October 09, 2026. Looking at past instances where ABT's MACD turned positive, the stock continued to rise in 32 of 54 cases over the following month. The odds of a continued upward trend are 59%.

ABT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in 170 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

The Aroon Indicator entered an Uptrend today. In 136 of 264 cases where ABT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Bearish Trend Analysis

The 10-day RSI Indicator for ABT moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 17 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 53 cases where ABT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

ABT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.722) is normal, around the industry mean (4.142). P/E Ratio (35.461) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.853) is also within normal values, averaging (11.253). Dividend Yield (0.023) settles around the average of (0.011) among similar stocks. P/S Ratio (3.836) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ZBH with price predictions
Nov 11, 2026

ZBH in upward trend: 10-day moving average broke above 50-day moving average on October 26, 2026

The 10-day moving average for ZBH crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on ZBH as a result. In 56 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for ZBH just turned positive on October 12, 2026. Looking at past instances where ZBH's MACD turned positive, the stock continued to rise in 27 of 44 cases over the following month. The odds of a continued upward trend are 61%.

ZBH moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZBH advanced for three days, in 196 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 126 of 221 cases where ZBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Bearish Trend Analysis

The 10-day RSI Indicator for ZBH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 23 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

ZBH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 12 (best 1 - 100 worst), indicating outstanding price growth. ZBH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.595) is normal, around the industry mean (4.142). P/E Ratio (25.629) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.576) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (2.233) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZBH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ABT vs ZBH: Fundamental Ratings
ABT
ZBH
OUTLOOK RATING
1..100
7970
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
6880
PRICE GROWTH RATING
1..100
4312
P/E GROWTH RATING
1..100
424
SEASONALITY SCORE
1..100
1875

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBH's Valuation (67) in the Medical Specialties industry is in the same range as ABT (78). This means that ZBH’s stock grew similarly to ABT’s over the last 12 months.

ABT's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as ZBH (100). This means that ABT’s stock grew similarly to ZBH’s over the last 12 months.

ABT's SMR Rating (68) in the Medical Specialties industry is in the same range as ZBH (80). This means that ABT’s stock grew similarly to ZBH’s over the last 12 months.

ZBH's Price Growth Rating (12) in the Medical Specialties industry is in the same range as ABT (43). This means that ZBH’s stock grew similarly to ABT’s over the last 12 months.

ABT's P/E Growth Rating (4) in the Medical Specialties industry is in the same range as ZBH (24). This means that ABT’s stock grew similarly to ZBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTZBH
RSI
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 1 day ago
61%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 10 days ago
56%
Bullish Trend 14 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 6 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
60%
Aroon
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
57%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ABT: $109.29 vs. ZBH: $107.47)
Brand notoriety: ABT: Notable vs. ZBH: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ABT: 97% vs. ZBH: 57%
Market capitalization -- ABT: $190.22B vs. ZBH: $20.14B
ABT [@Medical/Nursing Services] is valued at $190.22B. ZBH’s [@Medical/Nursing Services] market capitalization is $20.14B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 1 FA rating(s) are green while ZBH’s FA Score has 2 green FA rating(s).

  • ABT’s FA Score: 1 green, 4 red.
  • ZBH’s FA Score: 2 green, 3 red.
According to our system of comparison, both ABT and ZBH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 6 TA indicator(s) are bullish while ZBH’s TA Score has 6 bullish TA indicator(s).

  • ABT’s TA Score: 6 bullish, 4 bearish.
  • ZBH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ABT and ZBH are a good buy in the short-term.

Price Growth

ABT (@Medical/Nursing Services) experienced а -5.38% price change this week, while ZBH (@Medical/Nursing Services) price change was -2.43% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

ABT is expected to report earnings on Jan 27, 2027.

ZBH is expected to report earnings on Feb 11, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-1.06%
MDT - ABT
56%
Loosely correlated
+0.02%
SYK - ABT
53%
Loosely correlated
-1.70%
STE - ABT
47%
Loosely correlated
-0.33%
ZBH - ABT
44%
Loosely correlated
+0.14%
BAX - ABT
43%
Loosely correlated
-0.30%
More

ZBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with SYK. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBH
1D Price
Change %
ZBH100%
+0.14%
SYK - ZBH
64%
Loosely correlated
-1.70%
SNN - ZBH
58%
Loosely correlated
+0.39%
STE - ZBH
55%
Loosely correlated
-0.33%
MDT - ZBH
53%
Loosely correlated
+0.02%
ENOV - ZBH
50%
Loosely correlated
+1.17%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESTA70.693.46
+5.15%
Establishment Labs Holdings
RLMD4.430.16
+3.75%
Relmada Therapeutics
FIG18.970.34
+1.83%
Figma Inc
IPDN0.96-0.11
-10.66%
Professional Diversity Network Inc
INVZ0.18-0.04
-18.23%
Innoviz Technologies Ltd